advertisement
11.5.2 Topical (8)
Showing records 1 to 8
Display all abstracts in classification 11.5.2 Topical
Search within classification 11.5.2 Topical12096 Comparison of the efficacy and safety of dorzolamide 2% when added to brimonidine 0.2% or timolol maleate 0.5% in patients with primary open-angle glaucoma
Ozturk F; Ermis SS; Inan UU; Asagidag A; Yaman S
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 68-74
11973 Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model
Seki M; Tanaka T; Matsuda H; Togano T; Hashimoto K; Ueda J; Fukuchi T; Abe H
British Journal of Ophthalmology 2005; 89: 504-507
11750 Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification
Ermis SS; Ozturk F; Inan UU
Eye 2005; 19: 303-307
11843 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects
Konstas AG; Karabatsas CH; Lallos N; Georgiadis N; Kotsimpou A; Stewart JA; Stewart WC
Ophthalmology 2005; 112: 603-608
11918 Switching from latanoprost to fixed-combination latanoprost-timolol: A 2I -day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension
Olander K; Zimmerman TJ; Downes N; Schoenfelder J
Clinical Therapeutics 2004; 26: 1619-1629
11662 Development of a topical niosomal preparation of acetazolamide: Preparation and evaluation
Aggarwal D; Garg A; Kaur IP
Journal of Pharmacy and Pharmacology 2004; 56: 1509-1517
12103 Evaluation of topical brinzolamide switched from dorzolamide for glaucoma
Hasegawa K; Takahashi T; Kawase K
Japanese Journal of Clinical Ophthalmology 2005; 59: 215-219
11906 Dorzolamide influences the autoregulation of major retinal vessels caused by artificial intraocular pressure elevation in patients with POAG: A clinical study
Nagel E; Vilser W; Lanzl I
Current Eye Research 2005; 30: 129-137
